Page last updated: 2024-11-03

opc 12759 and Diseases, Occupational

opc 12759 has been researched along with Diseases, Occupational in 1 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Research Excerpts

ExcerptRelevanceReference
"The purpose of the study was to compare the two mucin secretogogues, diquafosol (DQS) and rebamipide (RBM), for the treatment of dry eye syndrome (DES) in office workers."5.24A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers. ( Fukagawa, K; Iwasaki, M; Okano, T; Saga, M; Sakata, M; Seika, D; Shimazaki, J, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimazaki, J1
Seika, D1
Saga, M1
Fukagawa, K1
Sakata, M1
Iwasaki, M1
Okano, T1

Trials

1 trial available for opc 12759 and Diseases, Occupational

ArticleYear
A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.
    Scientific reports, 2017, 11-09, Volume: 7, Issue:1

    Topics: Adult; Alanine; Conjunctiva; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Occupational Dise

2017